Stimson Susan P 4
4 · Intersect ENT, Inc. · Filed May 1, 2019
Insider Transaction Report
Form 4
Stimson Susan P
Vice President, Marketing
Transactions
- Exercise/Conversion
Common Stock
2019-04-29$21.06/sh+12,500$263,250→ 36,530 total - Sale
Common Stock
2019-04-29$31.06/sh−12,500$388,250→ 24,030 total - Exercise/Conversion
Stock Option (right to buy)
2019-04-29−12,500→ 0 totalExercise: $21.06Exp: 2025-01-20→ Common Stock (12,500 underlying)
Footnotes (4)
- [F1]Since the date of the reporting person's last ownership report, she transferred 19,085 shares of Intersect ENT, Inc. common stock and employee stock options to purchase 47,750 shares of Intersect ENT, Inc. common stock pursuant to a domestic relations order. The reporting person no longer reports such transferred securities as beneficially owned by her.
- [F2]Includes 10,017 Restricted Stock Units.
- [F3]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2019.
- [F4]The vesting commencement date of the option is January 1st, 2015. 1/8th of the shares subject to the option vested on July 1st, 2015 and 1/48th of the remaining shares subject to the option will vest monthly thereafter over 42 months.